This Article Full Text Full Text (PDF) All Versions of this Article: 50/2/269    most recent HYPERTENSIONAHA.107.091322v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, Y. Articles by Kellems, R. E. Search for Related Content PubMed PubMed Citation Articles by Xia, Y. Articles by Kellems, R. E. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Risk Pregnancy Related Collections ACE/Angiotension receptors Other hypertension

(Hypertension. 2007;50:269.)
© 2007 American Heart Association, Inc.

Brief Reviews

Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of Preeclampsia

From the Departments of Biochemistry and Molecular Biology (Y.X., R.E.K.) and Obstetrics, Gynecology and Reproductive Sciences (S.M.R.), University of Texas-Houston Medical School.

Correspondence to Yang Xia, Department of Biochemistry and Molecular Biology, PO Box 20708, University of Texas-Houston Medical School, Houston, TX 77225. E-mail yang.xia@uth.tmc.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Preeclampsia affects 7% of first pregnancies and is one of the leading causes of maternal and neonatal mortality and morbidity in the United States and the world.^1–3 The clinical hallmarks of the disorder include hypertension, proteinuria, hypercoagulability, edema, and placental abnormalities. In advanced stages, clinical symptoms include cerebral edema, renal failure, and the hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. The clinical management of preeclampsia is hampered by the lack of reliable diagnostic tests and effective therapy for the disorder. In some cases, termination of pregnancy is the only available option to prevent further deterioration of the fetus and mother. Fifteen percent of all preterm births are indicated early deliveries for preeclampsia.³ The resulting preterm births and the associated increased infant morbidity and mortality are especially disheartening consequences of preeclampsia.

Despite being one of the leading causes of maternal death and a major contributor to maternal and perinatal morbidity, the mechanisms responsible for the pathogenesis of preeclampsia are poorly understood. Roberts and colleagues^4,5 were among the first to propose that alterations in endothelial cell function by activating agents produced by the placenta initiate the clinical syndromes of preeclampsia. Circulating factors, such as inflammatory cytokines, endothelin, and soluble vascular endothelial growth factor receptor termed soluble fms-like tyrosine kinase-1 (sFlt-1), are elevated in preeclamptic women and are proposed to be important links between placental ischemia and endothelial dysfunction.^5–9 In particular, recent studies have shown that preeclampsia is associated with the presence of maternal autoantibodies capable of binding to and activating the . . . [Full Text of this Article]

This article has been cited by other articles:

				B. LaMarca, M. Parrish, L. F. Ray, S. R. Murphy, L. Roberts, P. Glover, G. Wallukat, K. Wenzel, K. Cockrell, J. N. Martin Jr, et al. Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats: Role of Endothelin-1 Hypertension, October 1, 2009; 54(4): 905 - 909. [Abstract] [Full Text] [PDF]

				S. A. Bainbridge, J.-S. Deng, and J. M. Roberts Increased Xanthine Oxidase in the Skin of Preeclamptic Women Reproductive Sciences, May 1, 2009; 16(5): 468 - 478. [Abstract] [PDF]

				B. LaMarca, G. Wallukat, M. Llinas, F. Herse, R. Dechend, and J. P. Granger Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor {alpha} in Pregnant Rats Hypertension, December 1, 2008; 52(6): 1168 - 1172. [Abstract] [Full Text] [PDF]

				B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]

				C. C. Zhou, S. Ahmad, T. Mi, S. Abbasi, L. Xia, M.-C. Day, S. M. Ramin, A. Ahmed, R. E. Kellems, and Y. Xia Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling Hypertension, April 1, 2008; 51(4): 1010 - 1019. [Abstract] [Full Text] [PDF]